Dr. Mohammed Hassan Al-Temimi, MD

Dr. Al-Temimi practices at Good Samaritan Hospital in San Jose, California, part of HCA Healthcare.

Dr. Al-Temimi's NPI, 1144562836, was assigned on March 21, 2013. Dr. Al-Temimi graduated from University of Baghdad College of Medicine in 2005. Dr. Al-Temimi's Indiana license number on file is 01082424A.

Dr. Al-Temimi's primary practice is Good Samaritan Hospital, at 2425 Samaritan Drive, San Jose, CA 95124 in Santa Clara County. The practice phone is (408) 559-2011.

Dr. Al-Temimi's primary practice is Good Samaritan Hospital in San Jose, California, part of HCA Healthcare. Dr. Al-Temimi is also affiliated with El Camino Health - Mountain View Hospital. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Al-Temimi to 2 more hospitals, 2 group practices and clinics, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al-Temimi practices, 7 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Al-Temimi's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Al-Temimi is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Al-Temimi's licenses on file in 2 states: Indiana and California.

CMS data shows 175 Medicare services from Dr. Al-Temimi across 6 procedure codes in 2024, for 148 Medicare patients. Medicare paid $26,469 for them.

CMS counts 148 Medicare patients who saw Dr. Al-Temimi in 2024. The largest group is 65 to 74, with 66 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Al-Temimi's median patient age at 62, with 50% women.

In 2024, Dr. Al-Temimi wrote 118 Medicare Part D claims for 52 patients. 91% of them were for generic drugs. CMS names the drug for 58 of them, across 4 drugs with 11 or more claims each, at $332 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

Dr. Al-Temimi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Al-Temimi as offering telehealth. CMS counts 16 procedures of removal of tissue by Dr. Al-Temimi, more than 67% of the clinicians it reports for that procedure.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 23 papers to Dr. Al-Temimi, published from 2016 to 2023. 2017 was the busiest year, with 4. The most frequent topics are Postoperative Complications, Laparoscopy and Propensity Score. Dr. Al-Temimi has published most often in Am J Surg. Dr. Al-Temimi's most frequent co-authors are Samir D. Johna, MD, Charles Nathan Trujillo, MD and Edwin Kim, MD.

CMS Open Payments shows 38 general payments to Dr. Al-Temimi from 6 drug and device companies from 2019 to 2025. Speaker and faculty fees make up the largest share, 85% of the total. Intuitive Surgical, Inc. paid the most, $37,088.

Dr. Al-Temimi graduated from University of Baghdad College of Medicine in 2005.

Dr. Al-Temimi is in network with 2 carriers, including Blue Cross Blue Shield of Michigan and CMS Medicare. HMO plans come from the most carriers, 1. Check the plan with the practice before a visit.